CN113122486A - Method for total biosynthesis of malonic acid - Google Patents

Method for total biosynthesis of malonic acid Download PDF

Info

Publication number
CN113122486A
CN113122486A CN201911420851.0A CN201911420851A CN113122486A CN 113122486 A CN113122486 A CN 113122486A CN 201911420851 A CN201911420851 A CN 201911420851A CN 113122486 A CN113122486 A CN 113122486A
Authority
CN
China
Prior art keywords
gene
malonic acid
recombinant
plasmid
escherichia coli
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201911420851.0A
Other languages
Chinese (zh)
Other versions
CN113122486B (en
Inventor
邓禹
赵运英
李诗韵
李国辉
毛银
周胜虎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangnan University
Original Assignee
Jiangnan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangnan University filed Critical Jiangnan University
Priority to CN201911420851.0A priority Critical patent/CN113122486B/en
Publication of CN113122486A publication Critical patent/CN113122486A/en
Application granted granted Critical
Publication of CN113122486B publication Critical patent/CN113122486B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0008Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/001Oxidoreductases (1.) acting on the CH-CH group of donors (1.3)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0012Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0014Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4)
    • C12N9/0016Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4) with NAD or NADP as acceptor (1.4.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1096Transferases (2.) transferring nitrogenous groups (2.6)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/04Alpha- or beta- amino acids
    • C12P13/06Alanine; Leucine; Isoleucine; Serine; Homoserine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/04Alpha- or beta- amino acids
    • C12P13/08Lysine; Diaminopimelic acid; Threonine; Valine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/04Alpha- or beta- amino acids
    • C12P13/12Methionine; Cysteine; Cystine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/04Alpha- or beta- amino acids
    • C12P13/20Aspartic acid; Asparagine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/40Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
    • C12P7/44Polycarboxylic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y102/00Oxidoreductases acting on the aldehyde or oxo group of donors (1.2)
    • C12Y102/01Oxidoreductases acting on the aldehyde or oxo group of donors (1.2) with NAD+ or NADP+ as acceptor (1.2.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y103/00Oxidoreductases acting on the CH-CH group of donors (1.3)
    • C12Y103/99Oxidoreductases acting on the CH-CH group of donors (1.3) with other acceptors (1.3.99)
    • C12Y103/99001Succinate dehydrogenase (1.3.99.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y104/00Oxidoreductases acting on the CH-NH2 group of donors (1.4)
    • C12Y104/01Oxidoreductases acting on the CH-NH2 group of donors (1.4) with NAD+ or NADP+ as acceptor (1.4.1)
    • C12Y104/01021Aspartate dehydrogenase (1.4.1.21)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y206/00Transferases transferring nitrogenous groups (2.6)
    • C12Y206/01Transaminases (2.6.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y401/00Carbon-carbon lyases (4.1)
    • C12Y401/01Carboxy-lyases (4.1.1)
    • C12Y401/01031Phosphoenolpyruvate carboxylase (4.1.1.31)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y403/00Carbon-nitrogen lyases (4.3)
    • C12Y403/01Ammonia-lyases (4.3.1)
    • C12Y403/01001Aspartate ammonia-lyase (4.3.1.1), i.e. aspartase
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention discloses a full biosynthesis method of malonic acid, and belongs to the technical field of bioengineering. The invention uses Escherichia coli BL21(DE3) as a host, and modular over-expresses phosphoenolpyruvate carboxylase gene (ppc), succinate dehydrogenase gene (sdhC), succinate semialdehyde dehydrogenase gene (yne1), aspartate enzyme gene (aspa), heterologous gene aspartate-alpha-dehydrogenase gene (panD) from Corynebacterium glutamicum and heterologous gene beta-alanine pyruvate transaminase gene (pa0123) from Pseudomonas aeruginosa, so that a complete biosynthesis pathway of malonic acid is constructed, and engineering bacteria can successfully accumulate malonic acid. The biological manufacture of the malonic acid and the precursor thereof has the advantages of less pollution, high product quality and the like, and has great development prospect.

Description

Method for total biosynthesis of malonic acid
Technical Field
The invention relates to a method for total biosynthesis of malonic acid, and belongs to the field of bioengineering.
Background
Malonic acid (malonic acid, malonate; Propane diacid) is also known as carotic acid, malic acid, or betainic acid. The molecular structure has two functional groups of active methylene and carboxyl, so that the compound can participate in various chemical reactions and is an important organic synthesis intermediate. The high-temperature-resistant flame-retardant epoxy resin is mainly applied to aspects of perfumes, adhesives, resin additives, medical intermediates, electroplating polishing agents, explosion control agents, thermal welding fluxing additives and the like.
At present, the method for hydrolyzing cyanoacetic acid and malonate is commonly used in industry to prepare malonic acid. However, the hydrolytic cyanoacetic acid method uses NaCN, and cyanide ions are extremely toxic, have great harm to the environment and have complex reaction process. The hydrolysis of malonate mainly uses dimethyl (ethyl) malonate to directly hydrolyze to prepare malonic acid, wherein the malonate is also neutralized by chloroacetic acid, cyanided and the like to prepare cyanoacetic acid, and then esterified to produce the malonate, which has the disadvantages of large environmental hazard and complex reaction process. And the malonic acid obtained by the two methods needs to be subjected to complicated and tedious purification procedures, so that the industrial production is limited.
In order to solve the above problems, attention has been focused on the way to biosynthesize malonic acid. However, due to the lack of knowledge of suitable enzymes and metabolic pathways, the research on the biological production of malonic acid has been slow. Malonic semialdehyde is an important precursor of malonic acid, but this conversion is difficult due to the absence of malonic semialdehyde dehydrogenase, and thus the progress of malonic acid biological production is slow.
Disclosure of Invention
In order to solve the problems, the invention firstly provides a recombinant escherichia coli for producing malonic acid, which takes escherichia coli BL21(DE3) as a host, and expresses phosphoenolpyruvate carboxylase gene (ppc), succinate dehydrogenase gene (sdhC), succinate semialdehyde dehydrogenase gene (yne1), aspartate enzyme gene (aspA), heterologous gene aspartate-alpha-dehydrogenase gene (panD) from corynebacterium glutamicum and heterologous gene beta-alanine pyruvate transaminase gene (pa0123) from pseudomonas aeruginosa in a modularized manner.
In one embodiment of the invention, the partial over-expression is fusion expression of genes yne1 and pa0123, fusion expression of genes aspa and panD, and fusion expression of genes sdhC and ppc.
In one embodiment, the nucleotide sequence of the ppc is shown as SEQ ID No.1, and the nucleotide sequence of the sdhC is shown as SEQ ID No. 2; the nucleotide sequence of the aspA is shown as SEQ ID NO.3, and the nucleotide sequence of the panD is shown as SEQ ID NO. 4; the nucleotide sequence of pa0123 is shown as SEQ ID NO.5, and the nucleotide sequence of yne1 is shown as SEQ ID NO. 6.
In one embodiment of the invention, the genes yne1 and pa0123 use pRSFDuet-1 as an expression vector; the genes aspa and panD take pTrc99a as an expression vector; the gene fragments sdhC and ppc use pCDFDuet-1 as an expression vector.
The invention also provides a method for constructing the recombinant escherichia coli, which comprises the following steps:
(1) connecting gene fragments yne1 and pa0123 by using the plasmid pRSFDuet-1 as a skeleton vector to obtain a recombinant plasmid pRSF-yne1-pa 0123;
(2) connecting gene fragments aspa and panD by taking the plasmid pTrc99a as a framework vector to obtain a recombinant plasmid pTrc99 a-aspa-panD;
(3) connecting gene fragments sdhC and ppc by using the plasmid pCDFDuet-1 as a skeleton vector to obtain a recombinant plasmid pCDF-sdhC-ppc;
(4) pRSF-yne1-pa0123, pTrc99a-aspa-panD and pCDF-sdhC-ppc were co-transferred into E.coli BL21(DE3) to obtain recombinant E.coli.
In one embodiment of the present invention, in step (1), the gene fragment pa0123 and the plasmid pRSFDuet-1 are cleaved with Nco I and Hind III enzymes, and then treated with T4DNA ligase is connected to obtain a recombinant plasmid pRSF-pa 0123; both yne1 and the recombinant plasmid pRSF-pa0123 were digested simultaneously with Xho I and Nde I, and then with T4And (3) connecting the DNA with ligase to obtain a recombinant plasmid pRSF-yne1-pa 0123.
In one embodiment of the present invention, in step (2), the gene fragment aspa and the plasmid pTrc99a are both Sal I and Xho IAfter enzymatic cleavage with T4DNA ligase is connected to obtain a recombinant plasmid pTrc99 a-aspa; panD and the recombinant plasmid pTrc99a-aspa were digested simultaneously with Xho I and Hind III, and then with T4The DNA ligases are connected to obtain the recombinant plasmid pTrc99 a-aspa-panD.
In one embodiment of the present invention, in step (3), the gene fragment sdhC and the plasmid pCDFDuet-1 are both digested with Nco I and EcoR I, and then treated with T4DNA ligase is connected to obtain a recombinant plasmid pCDF-sdhC; the ppc and the recombinant plasmid pCDF-sdhC were both digested with EcoR I and Sal I, followed by T4And (4) connecting the DNA with ligase to obtain a recombinant plasmid pCDF-sdhC-ppc.
The third purpose of the invention is to provide a method for producing malonic acid by fermenting the recombinant escherichia coli, which takes an SOB culture medium as a fermentation culture medium, and cultures the recombinant escherichia coli at 35-37 ℃ to OD600When the concentration is 0.6-0.8, 1mM IPTG is added and the temperature is reduced to 30 ℃ for induction culture for 48 hours.
In one embodiment of the invention, the composition of the SOB medium is 2g/100ml tryptone, 0.5g/100ml yeast powder, 0.05g/100ml NaCl, 2.5mM KCl, 10mM MgCl20.8g/100ml glucose, 50. mu.g/ml kanamycin sulfate, 50. mu.g/ml ampicillin, 50. mu.g/ml streptomycin.
In one embodiment of the present invention, the seed solution is prepared by streaking glycerol-preserved strain on a plate, picking a single colony and inoculating into a 250ml Erlenmeyer flask containing 50ml LB liquid medium, shaking at 37 deg.C and 250rpm/min overnight. Transferring 1ml of the bacterial liquid to 50ml of LB liquid culture medium the next day, culturing at 37 ℃ and 250rpm to OD600When reaching 0.6-0.8, the cells were inoculated into 50ml of SOB fermentation medium.
The invention also claims the application of the method in the preparation of malonic acid or a derivative product thereof.
Has the advantages that: compared with a chemical method, the Escherichia coli total biological method for synthesizing the malonic acid firstly takes glucose as a precursor, can be continuously developed, and greatly reduces the pollution degree to the environment. The method provided by the invention is a way for producing the malonic acid by fermenting the glucose, is a way with higher yield, provides environmental benefits by eliminating cyanide, chloroacetic acid and the like, can synthesize the malonic acid by utilizing the glucose by only over-expressing 2 genes, namely the heterologous gene aspartic acid-alpha-dehydrogenase gene (panD) from corynebacterium glutamicum and the heterologous gene beta-alanine pyruvate transaminase gene (pa0123) from pseudomonas aeruginosa without using other compounds as a premise, is simple, ensures that the high yield of the malonic acid of escherichia coli BL21(DE3) is possible due to mature fermentation process, and has the advantages of convenient operation and low cost, and the yield can reach 0.23g/L after 48 hours of fermentation.
Drawings
FIG. 1 is a malonic acid synthesis pathway.
FIG. 2 is a map of pRSF-yne1-pa0123 plasmid.
FIG. 3 is a map of pTrc99a-aspa-panD plasmid.
FIG. 4 is a map of the pCDF-sdhC-ppc plasmid.
FIG. 5 is a plasmid colony pcr validation map of pRSF-yne1-pa0123, 1: marker, 2-5: all the colonies are pRSF-yne1-pa0123 and pcr verifies pa 0123.
FIG. 6 is a graph of the results of fermentation of recombinant E.coli in SOB medium, IPTG 1 mM.
FIG. 7 is a liquid phase mass spectrometric detection profile of malonic acid; wherein, (A) is the liquid phase diagram of the malonic acid standard sample and the liquid phase diagram only showing the malonic acid standard sample; (B) respectively showing the mass spectrogram of a malonic acid standard sample and the mass spectrogram only showing malonic acid; (C) respectively showing a liquid phase diagram of a fermentation liquor sample and a liquid phase diagram only showing malonic acid in the fermentation liquor; (D) respectively showing the mass spectrogram of a fermentation liquor sample and the mass spectrogram of only malonic acid in the fermentation liquor; STANDARD is 1g/L of STANDARD malonic acid sample, and PA is a fermentation liquid sample.
Detailed Description
Liquid phase mass spectrum detection and result analysis of malonic acid:
pretreatment: centrifuging the fermentation sample at 12,000r/min for 2min to separate the fermentation liquid from the thallus, treating the fermentation liquid with a 0.22 μm filter membrane, and performing liquid phase mass spectrometry.
Liquid phase mass spectrum conditions: detection wavelength: 200-400n, analytical column: BEH C18(2.1 × 150mm 1.7.7 um), column temperature 45 ℃, flow rate: 0.3ml/min, sample size: 5 μ L, detector: waters Acquity PDA (200-400 nm).
The mobile phase conditions were as follows:
Figure BDA0002352346160000031
Figure BDA0002352346160000041
TABLE 1 primer sequence Listing in relation to the following examples
Figure BDA0002352346160000042
Example 1: constructing recombinant plasmid and obtaining recombinant Escherichia coli.
The nucleotide sequences of ppc, sdhC, aspA, panD, pa0123 and yne1 are shown in SEQ ID NO. 1-6 respectively.
Double digestion of plasmid pRSFDuet-1 with Nco I and Hind III, gel cutting to recover target gene fragment pRSF-1(3761bp), PCR amplification with primer pa0123-F/R and plasmid pUC57-pa0123 synthesized by Jinwei as template to obtain target gene fragment pa0123 (SEQ ID NO. 5), and T-digestion of both pRSF-1 and pa01234DNA ligase ligation, transformation JM109, colony PCR selection of positive transformants, plasmid restriction and PCR verification, verification of veri-pRSF-F/R primer, and verification of correct plasmid named pRSF-pa 0123.
Xho I and Nde I are used for enzyme digestion of plasmid pRSF-pa0123, gel cutting is carried out, a target gene fragment pRSF-2(5101bp) is recovered, the same enzyme digestion is carried out, large intestine genome is used as a template, a primer yne1-F/R is used, a yne1 fragment (shown as SEQ ID NO. 6) obtained through PCR amplification is used, and then two target fragments of pRSF-2 and yne1 are used as T4DNA ligase ligation, JM109 transformation, colony PCR selection of positive transformants, plasmid restriction and PCR verification, verification of veri-pRSF-F/R primer, and verification of correct plasmid designated pRSF-yne1-pa0123 (plasmid map is shown as figure in the specification)Shown at 2).
The plasmid pTrc99A was digested with Sal I and Xho I, the desired vector DNA fragment pTrc99A-1(4170bp) was recovered by cutting the gel, the genome of the large intestine was used as a template, the resulting aspa fragment (shown in SEQ ID NO. 3) was PCR-amplified with primer aspa-F/R by the same enzyme digestion, and then the two desired fragments pTrc99A-1 and aspa were subjected to T-cleavage with T4DNA ligase ligation, conversion JM109, colony PCR selection of positive transformants, plasmid digestion and PCR verification, verification of the primer veri-pTrc-F/R, and the verification of the correct plasmid named as pTrc99 a-aspa.
The plasmid pTrc99a-aspa was digested with Xho I and Hind III, the vector DNA fragment pTrc99A-2(5622bp) was recovered by gel cutting, the plasmid pUC57-panD synthesized by Kingson was digested with the same enzymes as the template, the target gene fragment panD (shown in SEQ ID NO. 4) was obtained by PCR amplification using the primer panD-F/R, and then the two target fragments pTrc99A-2 and panD were digested with T4DNA ligase ligation, JM109 transformation, colony PCR to pick up positive transformants, plasmid digestion and PCR verification are extracted, the primers are verified to be veri-pTrc-F/R, and the plasmid after verification is named as pTrc99a-aspa-panD (a plasmid map is shown in figure 3).
The plasmid pCDFDuet-1 is digested by Nco I and EcoR I, the DNA fragment pCDF-1(3744bp) of the target vector is recovered by cutting the gel, the genome of the large intestine is used as a template, the ppc fragment (shown as SEQ ID NO. 1) obtained by PCR amplification is digested by the same enzyme with the primer ppc-F/R, and then the two target fragments pCDF-1 and ppc are digested by T4DNA ligase ligation, transformation JM109, colony PCR selection of positive transformants, plasmid restriction enzyme digestion and PCR verification, verification primer veri-pCDF-F/R, and the plasmid after verification is named as pCDF-ppc.
Cutting plasmid pCDF-ppc with EcoR I and Sal I, cutting to recover target DNA fragment pCDF-2(6379bp), cutting with the same enzyme and using large intestine genome as template, PCR amplifying obtained sdhC fragment (shown as SEQ ID NO. 2) with primer sdhC-F/R, then cutting with T4DNA ligase ligation, JM109 transformation, colony PCR selection of positive transformants, plasmid restriction and PCR verification, verification primer veri-pCDF-F/R, verification of correct plasmid named pCDF-ppc-sdhC (plasmid map as figure)Shown at 4).
pRSF-yne1-pa0123, pTrc99a-aspa-panD and pCDF-sdhC-ppc were co-transferred into E.coli BL21(DE3) competent cells to prepare recombinant E.coli.
Example 2: shake flask fermentation and result analysis of recombinant escherichia coli.
Fermentation medium: SOB culture medium with components of 20g/L tryptone, 5g/L yeast powder, 0.5g/L NaCl, 2.5mM KCl, 10mM MgCl24g/L glucose, 50. mu.g/ml kanamycin sulfate, 50. mu.g/ml ampicillin, 50. mu.g/ml streptomycin.
Preparing a seed solution: the glycerol-preserved strain was streaked on a plate, and a single colony was picked and inoculated into a 250ml Erlenmeyer flask containing 50ml of LB liquid medium, and shaken overnight at 37 ℃ and 250 rpm/min.
Fermentation conditions are as follows: 2% inoculum size (1ml), inoculated in shake flask fermentation medium, to give initial OD600Is 0.1. Culturing at 37 deg.C and 250r/min to OD600When the concentration is 0.8-1.0 respectively, 1.0mM IPTG is added to induce the recombinant bacteria, and the culture is changed to 30 ℃ and 250 rpm/min.
And (4) analyzing results: sampling every 4H for the first 12H and every 12H for the last 60H during fermentation, centrifuging at 12,000r/min for 5min to separate the fermentation liquid from thallus, treating the fermentation liquid with 0.22 μm filter membrane for HPLC (high performance liquid chromatography, U.S. Bo Bio-Rad Bo Aminex HPX-87H organic acid column) detection with mobile phase of 5mM H2SO4The column temperature was 30 ℃ and the differential detector. According to the liquid phase results, no malonic acid production was detected for the first 24 hours, from 36 hours, malonic acid production was detected, and the yield reached a maximum of 0.23g/L at 48 hours.
Although the present invention has been described with reference to the preferred embodiments, it should be understood that various changes and modifications can be made therein by those skilled in the art without departing from the spirit and scope of the invention as defined in the appended claims.
SEQUENCE LISTING
<110> university of south of the Yangtze river
<120> method for total biosynthesis of malonic acid
<160> 6
<170> PatentIn version 3.3
<210> 1
<211> 2652
<212> DNA
<213> Escherichia coli
<400> 1
atgaacgaac aatattccgc attgcgtagt aatgtcagta tgctcggcaa agtgctggga 60
gaaaccatca aggatgcgtt gggagaacac attcttgaac gcgtagaaac tatccgtaag 120
ttgtcgaaat cttcacgcgc tggcaatgat gctaaccgcc aggagttgct caccacctta 180
caaaatttgt cgaacgacga gctgctgccc gttgcgcgtg cgtttagtca gttcctgaac 240
ctggccaaca ccgccgagca ataccacagc atttcgccga aaggcgaagc tgccagcaac 300
ccggaagtga tcgcccgcac cctgcgtaaa ctgaaaaacc agccggaact gagcgaagac 360
accatcaaaa aagcagtgga atcgctgtcg ctggaactgg tcctcacggc tcacccaacc 420
gaaattaccc gtcgtacact gatccacaaa atggtggaag tgaacgcctg tttaaaacag 480
ctcgataaca aagatatcgc tgactacgaa cacaaccagc tgatgcgtcg cctgcgccag 540
ttgatcgccc agtcatggca taccgatgaa atccgtaagc tgcgtccaag cccggtagat 600
gaagccaaat ggggctttgc cgtagtggaa aacagcctgt ggcaaggcgt accaaattac 660
ctgcgcgaac tgaacgaaca actggaagag aacctcggct acaaactgcc cgtcgaattt 720
gttccggtcc gttttacttc gtggatgggc ggcgaccgcg acggcaaccc gaacgtcact 780
gccgatatca cccgccacgt cctgctactc agccgctgga aagccaccga tttgttcctg 840
aaagatattc aggtgctggt ttctgaactg tcgatggttg aagcgacccc tgaactgctg 900
gcgctggttg gcgaagaagg tgccgcagaa ccgtatcgct atctgatgaa aaacctgcgt 960
tctcgcctga tggcgacaca ggcatggctg gaagcgcgcc tgaaaggcga agaactgcca 1020
aaaccagaag gcctgctgac acaaaacgaa gaactgtggg aaccgctcta cgcttgctac 1080
cagtcacttc aggcgtgtgg catgggtatt atcgccaacg gcgatctgct cgacaccctg 1140
cgccgcgtga aatgtttcgg cgtaccgctg gtccgtattg atatccgtca ggagagcacg 1200
cgtcataccg aagcgctggg cgagctgacc cgctacctcg gtatcggcga ctacgaaagc 1260
tggtcagagg ccgacaaaca ggcgttcctg atccgcgaac tgaactccaa acgtccgctt 1320
ctgccgcgca actggcaacc aagcgccgaa acgcgcgaag tgctcgatac ctgccaggtg 1380
attgccgaag caccgcaagg ctccattgcc gcctacgtga tctcgatggc gaaaacgccg 1440
tccgacgtac tggctgtcca cctgctgctg aaagaagcgg gtatcgggtt tgcgatgccg 1500
gttgctccgc tgtttgaaac cctcgatgat ctgaacaacg ccaacgatgt catgacccag 1560
ctgctcaata ttgactggta tcgtggcctg attcagggca aacagatggt gatgattggc 1620
tattccgact cagcaaaaga tgcgggagtg atggcagctt cctgggcgca atatcaggca 1680
caggatgcat taatcaaaac ctgcgaaaaa gcgggtattg agctgacgtt gttccacggt 1740
cgcggcggtt ccattggtcg cggcggcgca cctgctcatg cggcgctgct gtcacaaccg 1800
ccaggaagcc tgaaaggcgg cctgcgcgta accgaacagg gcgagatgat ccgctttaaa 1860
tatggtctgc cagaaatcac cgtcagcagc ctgtcgcttt ataccggggc gattctggaa 1920
gccaacctgc tgccaccgcc ggagccgaaa gagagctggc gtcgcattat ggatgaactg 1980
tcagtcatct cctgcgatgt ctaccgcggc tacgtacgtg aaaacaaaga ttttgtgcct 2040
tacttccgct ccgctacgcc ggaacaagaa ctgggcaaac tgccgttggg ttcacgtccg 2100
gcgaaacgtc gcccaaccgg cggcgtcgag tcactacgcg ccattccgtg gatcttcgcc 2160
tggacgcaaa accgtctgat gctccccgcc tggctgggtg caggtacggc gctgcaaaaa 2220
gtggtcgaag acggcaaaca gagcgagctg gaggctatgt gccgcgattg gccattcttc 2280
tcgacgcgtc tcggcatgct ggagatggtc ttcgccaaag cagacctgtg gctggcggaa 2340
tactatgacc aacgcctggt agacaaagca ctgtggccgt taggtaaaga gttacgcaac 2400
ctgcaagaag aagacatcaa agtggtgctg gcgattgcca acgattccca tctgatggcc 2460
gatctgccgt ggattgcaga gtctattcag ctacggaata tttacaccga cccgctgaac 2520
gtattgcagg ccgagttgct gcaccgctcc cgccaggcag aaaaagaagg ccaggaaccg 2580
gatcctcgcg tcgaacaagc gttaatggtc actattgccg ggattgcggc aggtatgcgt 2640
aataccggct aa 2652
<210> 2
<211> 390
<212> DNA
<213> Escherichia coli
<400> 2
atgataagaa atgtgaaaaa acaaagacct gttaatctgg acctacagac catccggttc 60
cccatcacgg cgatagcgtc cattctccat cgcgtttccg gtgtgatcac ctttgttgca 120
gtgggcatcc tgctgtggct tctgggtacc agcctctctt cccctgaagg tttcgagcaa 180
gcttccgcga ttatgggcag cttcttcgtc aaatttatca tgtggggcat ccttaccgct 240
ctggcgtatc acgtcgtcgt aggtattcgc cacatgatga tggattttgg ctatctggaa 300
gaaacattcg aagcgggtaa acgctccgcc aaaatctcct ttgttattac tgtcgtgctt 360
tcacttctcg caggagtcct cgtatggtaa 390
<210> 3
<211> 1437
<212> DNA
<213> Escherichia coli
<400> 3
atgtcaaaca acattcgtat cgaagaagat ctgttgggta ccagggaagt tccagctgat 60
gcctactatg gtgttcacac tctgagagcg attgaaaact tctatatcag caacaacaaa 120
atcagtgata ttcctgaatt tgttcgcggt atggtaatgg ttaaaaaagc cgcagctatg 180
gcaaacaaag agctgcaaac cattcctaaa agtgtagcga atgccatcat tgccgcatgt 240
gatgaagtcc tgaacaacgg aaaatgcatg gatcagttcc cggtagacgt ctaccagggc 300
ggcgcaggta cttccgtaaa catgaacacc aacgaagtgc tggccaatat cggtctggaa 360
ctgatgggtc accaaaaagg tgaatatcag tacctgaacc cgaacgacca tgttaacaaa 420
tgtcagtcca ctaacgacgc ctacccgacc ggtttccgta tcgcagttta ctcttccctg 480
attaagctgg tagatgcgat taaccaactg cgtgaaggct ttgaacgtaa agctgtcgaa 540
ttccaggaca tcctgaaaat gggtcgtacc cagctgcagg acgcagtacc gatgaccctc 600
ggtcaggaat tccgcgcttt cagcatcctg ctgaaagaag aagtgaaaaa catccaacgt 660
accgctgaac tgctgctgga agttaacctt ggtgcaacag caatcggtac tggtctgaac 720
acgccgaaag agtactctcc gctggcagtg aaaaaactgg ctgaagttac tggcttccca 780
tgcgtaccgg ctgaagacct gatcgaagcg acctctgact gcggcgctta tgttatggtt 840
cacggcgcgc tgaaacgcct ggctgtgaag atgtccaaaa tctgtaacga cctgcgcttg 900
ctctcttcag gcccacgtgc cggcctgaac gagatcaacc tgccggaact gcaggcgggc 960
tcttccatca tgccagctaa agtaaacccg gttgttccgg aagtggttaa ccaggtatgc 1020
ttcaaagtca tcggtaacga caccactgtt accatggcag cagaagcagg tcagctgcag 1080
ttgaacgtta tggagccggt cattggccag gccatgttcg aatccgttca cattctgacc 1140
aacgcttgct acaacctgct ggaaaaatgc attaacggca tcactgctaa caaagaagtg 1200
tgcgaaggtt acgtttacaa ctctatcggt atcgttactt acctgaaccc gttcatcggt 1260
caccacaacg gtgacatcgt gggtaaaatc tgtgccgaaa ccggtaagag tgtacgtgaa 1320
gtcgttctgg aacgcggtct gttgactgaa gcggaacttg acgatatttt ctccgtacag 1380
aatctgatgc acccggctta caaagcaaaa cgctatactg atgaaagcga acagtaa 1437
<210> 4
<211> 411
<212> DNA
<213> Corynebacterium glutamicum
<400> 4
atgttgcgta ctatcctggg ctccaaaatt catcgtgcca ccgtcacgca ggcagacttg 60
gattatgtgg gctccgtgac catcgacgcg gacttagtcc acgccgccgg gttgatcgaa 120
ggcgagaaag tggcgattgt agacattacc aacggggctc gcttggaaac ttatgtcatt 180
gtgggtgatg cgggaactgg gaacatctgc attaacgggg ccgcagctca tctgatcaat 240
ccgggcgatt tggtgatcat catgtcatat ttgcaagcga cggatgcaga agctaaagca 300
tatgagccga agatcgtcca tgtcgacgct gataaccgca ttgtggcgct gggaaacgac 360
ctggctgagg ccttgccagg ttcaggcctt ttaaccagtc gctcgatcta g 411
<210> 5
<211> 1347
<212> DNA
<213> Pseudomona aeruginosa
<400> 5
atgaatcagc ccctgaatgt cgctccgccc gtgagctcgg aattaaacct gcgcgcccac 60
tggatgccat tttcggctaa ccgcaatttc caaaaagacc cgcgtattat cgtcgcggcg 120
gagggctcct ggctgaccga cgacaagggc cgtaaagtat acgatagcct gtcaggatta 180
tggacctgcg gtgcggggca tagccgcaag gaaattcagg aagcggttgc tcgtcaactg 240
gggactttgg actattcgcc aggattccaa tatggacatc cattgtcttt ccagttggcc 300
gagaagattg ctgggttatt acctggggaa ttaaaccatg tcttttttac gggatcaggg 360
tcggagtgcg cagacacttc gattaagatg gcccgcgcct actggcgctt aaagggacaa 420
ccccagaaga ctaagctgat tggacgcgca cgcggttacc acggcgtgaa tgtcgcgggc 480
acaagccttg gagggatcgg ggggaaccgc aagatgttcg gacagctgat ggatgtggac 540
catcttcccc atacccttca gccaggtatg gcattcactc gcgggatggc gcagacagga 600
ggcgttgaac tggcgaatga gttattaaag ttaattgaat tgcacgatgc gtctaacatc 660
gcagcggtta ttgtcgagcc catgtccggt tccgcaggag ttttagtgcc acccgtgggc 720
tatctgcagc gtttgcgcga aatctgtgac caacacaata ttctgcttat ctttgatgaa 780
gtgattacgg ctttcgggcg tctgggtact tactcgggag ccgaatactt cggggtcacg 840
ccggacttga tgaatgttgc aaaacaggtc acgaatggtg cagtacctat gggtgctgta 900
atcgcctcta gcgagattta cgatactttc atgaaccagg cgctgcctga acatgcggtt 960
gaattttccc acggttatac atattcagcg cacccagtgg catgtgctgc gggattagca 1020
gcactggaca tcttggcgcg cgataactta gtacagcagt cagcagagtt agctccacac 1080
ttcgagaagg gattgcatgg ccttcaaggt gccaagaatg ttatcgacat tcgcaactgc 1140
ggcttagcag gcgcgatcca gatcgctccc cgtgatgggg atccgacagt tcgccccttt 1200
gaagccggga tgaaactgtg gcaacaaggg ttttacgtcc gtttcggcgg cgacactctg 1260
cagtttgggc caacatttaa tgcacgccca gaggaattgg accgtctttt tgacgctgta 1320
ggtgaggctc tgaacggaat tgcctga 1347
<210> 6
<211> 1149
<212> DNA
<213> Escherichia coli
<400> 6
aaaccaatca accaggcgcg cgctgaagtg gcgaaatcgg cgaatttgtg tgactggtat 60
gcagaacatg gtccggcaat gctgaaggcg gaacctacgc tggtggaaaa tcagcaggcg 120
gttattgagt atcgaccgtt ggggacgatt ctggcgatta tgccgtggaa ttttccgtta 180
tggcaggtga tgcgtggcgc tgttcccatc attcttgcag gtaacggcta cttacttaaa 240
catgcgccga atgtgatggg ctgtgcacag ctcattgccc aggtgtttaa agatgcgggt 300
atcccacaag gcgtatatgg ctggctgaat gccgacaacg acggtgtcag tcagatgatt 360
aaagactcgc gcattgctgc tgtcacggtg accggaagtg ttcgtgcggg agcggctatt 420
ggcgcacagg ctggagcggc actgaaaaaa tgcgtactgg aactgggcgg ttcggatccg 480
tttattgtgc ttaacgatgc cgatctggaa ctggcggtga aagcggcggt agccggacgt 540
tatcagaata ccggacaggt atgtgcagcg gcaaaacgct ttattatcga agagggaatt 600
gcttcggcat ttaccgaacg ttttgtggca gctgcggcag ccttgaaaat gggcgatccc 660
cgtgacgaag agaacgctct cggaccaatg gctcgttttg atttacgtga tgagctgcat 720
catcaggtgg agaaaaccct ggcgcagggt gcgcgtttgt tactgggcgg ggaaaagatg 780
gctggggcag gtaactacta tccgccaacg gttctggcga atgttacccc agaaatgacc 840
gcgtttcggg aagaaatgtt tggccccgtt gcggcaatca ccattgcgaa agatgcagaa 900
catgcactgg aactggctaa tgatagtgag ttcggccttt cagcgaccat ttttaccact 960
gacgaaacac aggccagaca gatggcggca cgtctggaat gcggtggggt gtttatcaat 1020
ggttattgtg ccagcgacgc gcgagtggcc tttggtggcg tgaaaaagag tggctttggt 1080
cgtgagcttt cccatttcgg cttacacgaa ttctgtaata tccagacggt gtggaaagac 1140
cggatctga 1149

Claims (10)

1. The recombinant Escherichia coli for producing the malonic acid is characterized in that Escherichia coli BL21(DE3) is used as a host, and phosphoenolpyruvate carboxylase genes, succinate dehydrogenase genes, succinate semialdehyde dehydrogenase genes and aspartate enzyme genes from the Escherichia coli, heterologous genes aspartate-alpha-dehydrogenase genes from Corynebacterium glutamicum and beta-alanine pyruvate transaminase genes from Pseudomonas aeruginosa are expressed in a modularized over-expression manner.
2. The recombinant Escherichia coli of claim 1, wherein said modular overexpression is fusion expression of a succinate semialdehyde dehydrogenase gene and a β -alanine pyruvate transaminase gene, fusion expression of an aspartate gene and an aspartate- α -dehydrogenase gene, and fusion expression of a succinate dehydrogenase gene and a phosphoenolpyruvate carboxylase gene.
3. The recombinant Escherichia coli of claim 1 or 2, wherein the nucleotide sequence of the phosphoenolpyruvate carboxylase gene is represented by SEQ ID No.1, and the nucleotide sequence of the succinate dehydrogenase gene is represented by SEQ ID No. 2; the nucleotide sequence of the aspartate gene is shown as SEQ ID NO.3, and the nucleotide sequence of the aspartate-alpha-dehydrogenase gene is shown as SEQ ID NO. 4; the nucleotide sequence of the beta-alanine pyruvate transaminase gene is shown as SEQ ID NO.5, and the nucleotide sequence of the succinic semialdehyde dehydrogenase gene is shown as SEQ ID NO. 6.
4. The recombinant E.coli of claim 3, wherein the vector for modular overexpression is selected from the group consisting of pRSFDuet-1, pTrc99a and pCDFDuet-1.
5. A method for constructing the recombinant Escherichia coli of claim 4, comprising the steps of:
(1) connecting gene fragments yne1 and pa0123 by using the plasmid pRSFDuet-1 as a skeleton vector to obtain a recombinant plasmid pRSF-yne1-pa 0123;
(2) connecting gene fragments aspa and panD by taking the plasmid pTrc99a as a framework vector to obtain a recombinant plasmid pTrc99 a-aspa-panD;
(3) connecting gene fragments sdhC and ppc by using the plasmid pCDFDuet-1 as a skeleton vector to obtain a recombinant plasmid pCDF-sdhC-ppc;
(4) pRSF-yne1-pa0123, pTrc99a-aspa-panD and pCDF-sdhC-ppc were co-transferred into E.coli BL21(DE3) to obtain recombinant E.coli.
6. A method for producing malonic acid, comprising inoculating the recombinant Escherichia coli of any one of claims 1 to 4 to a fermentation medium containing glucose, and fermenting to produce malonic acid.
7. The method of claim 6, wherein the recombinant Escherichia coli is cultured to OD at 35-37 ℃600When the concentration is 0.6-0.8, IPTG is added for induction.
8. The method of claim 7, wherein the inducing is performed at 28-30 ℃ for 36-60 h.
9. The method according to any one of claims 6 to 8, wherein the fermentation medium is an SOB medium.
10. Use of the recombinant E.coli of any one of claims 1 to 4 or the method of any one of claims 6 to 9 for the preparation of malonic acid or a derivative thereof.
CN201911420851.0A 2019-12-31 2019-12-31 Method for total biosynthesis of malonic acid Active CN113122486B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201911420851.0A CN113122486B (en) 2019-12-31 2019-12-31 Method for total biosynthesis of malonic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201911420851.0A CN113122486B (en) 2019-12-31 2019-12-31 Method for total biosynthesis of malonic acid

Publications (2)

Publication Number Publication Date
CN113122486A true CN113122486A (en) 2021-07-16
CN113122486B CN113122486B (en) 2023-06-13

Family

ID=76769533

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201911420851.0A Active CN113122486B (en) 2019-12-31 2019-12-31 Method for total biosynthesis of malonic acid

Country Status (1)

Country Link
CN (1) CN113122486B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113817782A (en) * 2021-09-27 2021-12-21 江南大学 Total biosynthesis method of pimelic acid
CN114736841A (en) * 2022-04-02 2022-07-12 万华化学集团股份有限公司 Recombinant escherichia coli and preparation method and application thereof
CN116135981A (en) * 2021-11-18 2023-05-19 中国科学院天津工业生物技术研究所 Method for synthesizing malonic acid and application

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1256314A (en) * 1998-12-01 2000-06-14 底古萨-胡尔斯股份公司 Fermentation process for preparing D-pantothenic acid by amplifying PAND gene in microbe
CN107787361A (en) * 2015-03-20 2018-03-09 韩国科学技术院 Generate the mutant microbial of L aspartames and the method using mutant microbial generation L aspartames
CN108884464A (en) * 2016-01-11 2018-11-23 韩国科学技术院 The method for generating the recombination mutation microorganism of ability with malonic acid and generating malonic acid using it
CN110592153A (en) * 2014-06-23 2019-12-20 Cj第一制糖株式会社 Microorganism producing O-acetylhomoserine and method for producing O-acetylhomoserine using the same

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1256314A (en) * 1998-12-01 2000-06-14 底古萨-胡尔斯股份公司 Fermentation process for preparing D-pantothenic acid by amplifying PAND gene in microbe
CN110592153A (en) * 2014-06-23 2019-12-20 Cj第一制糖株式会社 Microorganism producing O-acetylhomoserine and method for producing O-acetylhomoserine using the same
CN107787361A (en) * 2015-03-20 2018-03-09 韩国科学技术院 Generate the mutant microbial of L aspartames and the method using mutant microbial generation L aspartames
CN108884464A (en) * 2016-01-11 2018-11-23 韩国科学技术院 The method for generating the recombination mutation microorganism of ability with malonic acid and generating malonic acid using it

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHAN WOO SONG等: "Metabolic Engineering of Escherichia coli for the Production of 3‑Hydroxypropionic Acid and Malonic Acid through β‑Alanine Route", 《ACS SYNTHETIC BIOLOGY》 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113817782A (en) * 2021-09-27 2021-12-21 江南大学 Total biosynthesis method of pimelic acid
CN113817782B (en) * 2021-09-27 2023-08-25 江南大学 Full biosynthesis method of pimelic acid
CN116135981A (en) * 2021-11-18 2023-05-19 中国科学院天津工业生物技术研究所 Method for synthesizing malonic acid and application
CN114736841A (en) * 2022-04-02 2022-07-12 万华化学集团股份有限公司 Recombinant escherichia coli and preparation method and application thereof
CN114736841B (en) * 2022-04-02 2023-12-19 万华化学集团股份有限公司 Recombinant escherichia coli as well as preparation method and application thereof

Also Published As

Publication number Publication date
CN113122486B (en) 2023-06-13

Similar Documents

Publication Publication Date Title
US7262037B2 (en) Method for the production of D-(-)-3-hydroxybutyric acid by recombinant Escherichia coli
CN113122486B (en) Method for total biosynthesis of malonic acid
CN111254129B (en) Polyphosphate kinase mutant and application thereof
CN106957850B (en) Genetically engineered bacterium for producing phospholipase D and construction method and application thereof
CN105647844B (en) Recombinant bacterium for producing glycolic acid by using xylose and construction method and application thereof
CN108753808B (en) Recombinant expression vector, recombinant expression host and method for synthesizing adenosine triphosphate by using recombinant expression vector
CN102994439A (en) Escherichia coli recombinant strain producing shikimic acid, and construction method and application thereof
CN114107152B (en) Construction method and application of high-yield 3-fucosyllactose microorganism
CN113462666B (en) Carbonyl reductase mutant and application thereof
CN111019878A (en) Recombinant escherichia coli with improved L-threonine yield as well as construction method and application thereof
KR20220139351A (en) Modified Microorganisms and Methods for Improved Production of Ectoins
CN111454998B (en) Biological preparation method of chiral hydroxy acid ester
CN114874964A (en) Construction method and application of recombinant escherichia coli for high yield of 2&#39; -fucosyllactose
CN106011185B (en) method for improving glycolic acid yield in escherichia coli through gene-free knockout
CN109112090B (en) Total biosynthesis method of glutaric acid
US20110318795A1 (en) Dicarboxylic acid production in a filamentous fungus
CN113583925B (en) Method for preparing patchouli alcohol by fermenting metabolic engineering escherichia coli
CN113637620B (en) Construction method and application of clavulanic acid high-yield strain
CN113832087B (en) Method for total biosynthesis of malonic acid by using escherichia coli
CN114806913A (en) High-yield succinic acid yeast engineering strain with mitochondrion positioning reduction TCA (trichloroacetic acid) approach as well as construction method and application thereof
CN108884465B (en) Modified microorganism having acrylic acid-producing ability and method for producing acrylic acid using the same
CN114736841B (en) Recombinant escherichia coli as well as preparation method and application thereof
CN114381412B (en) Recombinant bacterium for synthesizing 3-hydroxy propionic acid and construction method and application thereof
CN112011523B (en) Acetylacetone lyase mutant capable of improving acetylacetone synthesis efficiency, gene, expression vector, cell and application thereof
US20240052382A1 (en) Process control for 3-hydroxypropionic acid production by engineered strains of aspergillus niger

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant